Status:
UNKNOWN
Evaluation of the Relevance of Comparative Genomic Hybridization in Prenatal Diagnosis
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Comparative Genomic Hybridization
Eligibility:
FEMALE
Brief Summary
Pre-natal diagnosis is developing nowadays thanks to the improvement of ultrasound performances but also of genetic analysis techniques. The karyotype was previously the reference technique for genet...
Eligibility Criteria
Inclusion
- CGH-array performed for ultrasound findings at the genetic laboratory of the Nancy University Hospital from 01/10/2012 to 31/12/2018
- Results of the CGH-array presented to the multidisciplinary pre-natal diagnosis committee of Nancy
Exclusion
- patients who objected to the use of their data for research purposes when signing the informed consent form given during the genetic consultation
Key Trial Info
Start Date :
March 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
830 Patients enrolled
Trial Details
Trial ID
NCT04814563
Start Date
March 30 2021
End Date
April 1 2021
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nancy University Hospital
Nancy, France, 54000